← Leaderboards
Jonathan Mark Petrash
Washington University
$13,263,504
Attributed
$14,370,234
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$20,108,260 · 14
By mechanism
R01$12,546,894 · 4
P30$6,084,581 · 3
RC1$992,398 · 1
R13$360,500 · 1
T35$73,592 · 1
P41$50,295 · 4
Top collaborators
- Daniel V. Labarbera8 shared
- Randal G Ross5 shared
Most similar at Washington University
Same institution · by research overlap
- Vijay Sharma$15,781,488
- Thaddeus J Wadas$698,000
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventEye DiseasesCataractDiabetic CataractAldehyde ReductaseBlindnessLensPathogenesisGenesDiabetes MellitusDiabetic RetinopathyMouse ModelAnimal ModelDiabeticDesignAmericanTransgenic MiceInhibitor/AntagonistLeadPhenotypeGeneral PopulationRetinal DiseasesFaceVision
Grant awards (64)
Awarding of travel grants to early-career clinician scientists to attend the Association for Research in Vision and Ophthalmology annual meeting (2018-2022).$72,100
R13 · FY2022 · EY · contact PI
Molecular Signaling in Cataracts$377,087
R01 · FY2021 · EY · contact PI
Awarding of travel grants to early-career clinician scientists to attend the Association for Research in Vision and Ophthalmology annual meeting (2018-2022).$72,100
R13 · FY2021 · EY · contact PI
Molecular Signaling in Cataracts$388,750
R01 · FY2020 · EY · contact PI
Awarding of travel grants to early-career clinician scientists to attend the Association for Research in Vision and Ophthalmology annual meeting (2018-2022).$72,100
R13 · FY2020 · EY · contact PI
Molecular Signaling in Cataracts$388,750
R01 · FY2019 · EY · contact PI
Awarding of travel grants to early-career clinician scientists to attend the Association for Research in Vision and Ophthalmology annual meeting (2018-2022).$72,100
R13 · FY2019 · EY · contact PI
Molecular Signaling in Cataracts$388,750
R01 · FY2018 · EY · contact PI
Molecular Signaling in Cataracts$194,375
R01 · FY2018 · EY · contact PI
Awarding of travel grants to early-career clinician scientists to attend the Association for Research in Vision and Ophthalmology annual meeting (2018-2022).$72,100
R13 · FY2018 · EY · contact PI
Molecular Signaling in Cataracts$388,750
R01 · FY2017 · EY · contact PI
Novel Therapeutics Against Diabetic Eye Disease$426,772
R01 · FY2015 · EY · contact PI
Vision Research Training Program$9,763
T35 · FY2015 · EY · contact PI
Aldose Reductase and Diabetic Eye Disease$443,601
R01 · FY2014 · EY · contact PI
Novel Therapeutics Against Diabetic Eye Disease$426,783
R01 · FY2014 · EY · contact PI
Vision Research Training Program$13,098
T35 · FY2014 · EY · contact PI
Aldose Reductase and Diabetic Eye Disease$430,021
R01 · FY2013 · EY · contact PI
Novel Therapeutics Against Diabetic Eye Disease$359,102
R01 · FY2013 · EY · contact PI
Novel Therapeutics Against Diabetic Eye Disease$57,471
R01 · FY2013 · EY · contact PI
Vision Research Training Program$13,268
T35 · FY2013 · EY · contact PI
Aldose Reductase and Diabetic Eye Disease$452,654
R01 · FY2012 · EY · contact PI
Novel Therapeutics Against Diabetic Eye Disease$378,133
R01 · FY2012 · EY · contact PI
Novel Therapeutics Against Diabetic Eye Disease$67,655
R01 · FY2012 · EY · contact PI
Novel Therapeutics Against Diabetic Eye Disease$56,292
R01 · FY2012 · EY · contact PI
Vision Research Training Program$18,887
T35 · FY2012 · EY · contact PI
Aldose Reductase and Diabetic Eye Disease$452,654
R01 · FY2011 · EY · contact PI
Novel Therapeutics Against Diabetic Eye Disease$367,660
R01 · FY2011 · EY · contact PI
Vision Research Training Program$18,576
T35 · FY2011 · EY · contact PI
Aldose Reductase and Diabetic Eye Disease$501,993
R01 · FY2010 · EY · contact PI
Development of Small Heat Shock Proteins as Therapeutic Agents in the Eye$493,174
RC1 · FY2010 · EY · contact PI
Development of Small Heat Shock Proteins as Therapeutic Agents in the Eye$499,224
RC1 · FY2009 · EY · contact PI
ALDOSE REDUCTASE AND DIABETIC EYE DISEASE$5,825
P41 · FY2009 · RR · contact PI
MOLECULAR INTERACTIONS OF CRYSTALLINS IN THE EYE$5,825
P41 · FY2009 · RR · contact PI
CORE GRANT FOR VISION RESEARCH$781,353
P30 · FY2008 · EY · contact PI
Aldose Reductade and Diabetic Eye Disease$514,636
R01 · FY2008 · EY · contact PI
ALDOSE REDUCTADE AND DIABETIC EYE DISEASE$27,831
P41 · FY2008 · RR · contact PI
MOLECULAR INTERACTIONS OF CRYSTALLINS IN THE EYE$10,814
P41 · FY2008 · RR · contact PI
CORE GRANT FOR VISION RESEARCH$759,501
P30 · FY2007 · EY · contact PI
Aldose Reductase and Diabetic Eye Disease$505,317
R01 · FY2007 · EY · contact PI
CORE GRANT FOR VISION RESEARCH$738,288
P30 · FY2006 · EY · contact PI
Aldose Reductade and Diabetic Eye Disease$517,051
R01 · FY2006 · EY · contact PI
Aldose Reductade and Diabetic Eye Disease$29,894
R01 · FY2006 · EY · contact PI
CORE GRANT FOR VISION RESEARCH$717,697
P30 · FY2005 · EY
Aldose Reductase and Diabetic Eye Disease$474,761
R01 · FY2005 · EY
Molecular Interactions of Crystallins in the Eye$358,690
R01 · FY2005 · EY
CORE-ADMINISTRATION$83,641
P30 · FY2005 · EY
CORE GRANT FOR VISION RESEARCH$764,498
P30 · FY2004 · EY
ALDOSE REDUCTASE AND DIABETIC EYE DISEASE$456,381
R01 · FY2004 · EY
Molecular Interactions of Crystallins in the Eye$344,250
R01 · FY2004 · EY
Molecular Interactions of Crystallins in the Eye$12,359
R01 · FY2004 · EY
CORE GRANT FOR VISION RESEARCH$607,723
P30 · FY2003 · EY
ALDOSE REDUCTASE AND DIABETIC EYE DISEASE$443,089
R01 · FY2003 · EY
Molecular Interactions of Crystallins in the Eye$344,250
R01 · FY2003 · EY
CORE GRANT FOR VISION RESEARCH$478,763
P30 · FY2002 · EY
ALDOSE REDUCTASE AND DIABETIC EYE DISEASE$430,184
R01 · FY2002 · EY
Molecular Interactions of Crystallins in the Eye$374,625
R01 · FY2002 · EY
CORE--MOLECULAR BIOLOGY$87,638
P30 · FY2002 · EY
ALDOSE REDUCTASE AND DIABETIC EYE DISEASE$517,959
R01 · FY2001 · EY
CORE GRANT FOR VISION RESEARCH$452,013
P30 · FY2001 · EY
CORE--MOLECULAR BIOLOGY$87,638
P30 · FY2001 · EY
CORE GRANT FOR VISION RESEARCH$438,190
P30 · FY2000 · EY
ALDOSE REDUCTASE AND DIABETIC EYE DISEASE$426,194
R01 · FY2000 · EY
ALDOSE REDUCTASE AND DIABETIC EYE DISEASE$250,001
R01 · FY2000 · EY
CORE--MOLECULAR BIOLOGY$87,638
P30 · FY2000 · EY